Topic
pharmaceutical-compounding
2 stories related to this topic, newest first.
The Guardianscience1 day ago
FDA advisers to review research peptide access in July meeting
Advisers to the Food and Drug Administration will meet on 23-24 July to consider easing restrictions on seven research peptides currently sold in a gray market. The discussion follows a 2023 ban on compounding pharmacies producing the substances due to safety concerns.
Substrate placeholder — needs reviewworld74 days ago
HHS Secretary Robert F. Kennedy Jr. Seeks to Ease Restrictions on Certain Peptides
Health and Human Services Secretary Robert F. Kennedy Jr. is advocating for reduced restrictions on 14 synthetic peptides currently classified as Category 2 by the FDA. This move aims to allow licensed compounding pharmacies to produce them for patient use. Physicians have shared…